Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;3(4):242-9.
doi: 10.3978/j.issn.2218-6751.2013.12.05.

Recurrence after surgery in patients with NSCLC

Affiliations
Review

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto et al. Transl Lung Cancer Res. 2014 Aug.

Abstract

Surgery remains the only potentially curative modality for early-stage non-small cell lung cancer (NSCLC) patients and tissue availability is made possible. However, a proportion of lung cancer patients develop recurrence, even after curative resection. This review discusses the superiority of surgery, the reasons for recurrence, the timing and pattern of recurrence, the identification of factors related to recurrence, current provisions for treatment and perspectives about surgery for patients with NSCLC.

Keywords: Recurrence; disease-free survival (DFS); non-small cell lung cancer (NSCLC); relapse; surgery.

PubMed Disclaimer

References

    1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. - PubMed
    1. Mitsudomi T, Suda K, Yatabe Y.Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol 2013;10:235-44. - PubMed
    1. al-Kattan K, Sepsas E, Fountain SW, et al. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 1997;12:380-4. - PubMed
    1. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000;355:479-85. - PubMed
    1. Carnio S, Novello S, Papotti M, et al. Prognostic and predictive biomarkers in early stage non small-cell lung cancer: tumor based approaches including gene signatures. Transl Lung Cancer Res 2013;2:372-81. - PMC - PubMed